Agenus reported $64.42M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Agenus AGEN:US USD 64.42M 1.07M
Amgen AMGN:US USD 3.91B 504M
AstraZeneca AZN:LN USD 9.74B 495M
Bristol Myers Squibb BMY:US USD 8.75B 552M
Celldex Therapeutics CLDX:US USD 28.1M 8.46M
CSL CSL:AU USD 3.81B 18.5M
Dynavax Technologies DVAX:US USD 106.34M 21.9M
Eli Lilly And LLY:US USD 5.27B 12.8M
Genocea Biosciences GNCA:US USD 16.04M 2.63M
Gilead Sciences GILD:US USD 4.2B 26M
GlaxoSmithKline GSK:LN GBP 6.64B 790M
Glaxosmithkline GSK:US GBP 6.64B 790M
Immunogen IMGN:US USD 92.8M 17.59M
Intrexon XON:US USD 24.34M 2.74M
Jiangsu Hengrui Me. 600276:CH CNY 4.46B 747.46M
Johnson & Johnson JNJ:US USD 17.97B 211M
Karyopharm Therapeutics KPTI:US USD 66.98M 15.6M
Macrogenics MGNX:US USD 66.69M 1.13M
Merck MRK:GR EUR 4.57B 181M
Merk MRK:US USD 10.97B 1.31B
Northwest Biotherapeutics NWBO:US USD 16.28M 5.41M
Novartis NOVN:VX USD 10.67B 183M
Novavax NVAX:US USD 861.77M 192.88M
Pfizer PFE:US USD 13.23B 2.41B
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Rigel Pharmaceuticals RIGL:US USD 40.81M 1.97M
Sangamo Biosciences SGMO:US USD 81.35M 6.24M
Veracyte VCYT:US USD 85.27M 1.67M
YTE INCY:US USD 684.93M 27.96M